GovChime
UEI: NG61ZA8TADW3 • CAGE: 04520

Novartis Pharmaceuticals Corporation (NJ)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2008
$85.88M
$85,878,289under this UEI
FY2026 obligations
$40.09M
$40,085,448ProvisionalFY2027 to date: $8.40M
Awards and orders
665
with positive net obligations14 IDV vehicles held
Latest action
Oct 13, 2026
SAM.gov registration
Active
Registration expiration date Jun 17, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jan 1, 1996 (30 years)
Location
East Hanover, NJ
State of incorporation
Delaware
Purpose of registration
All Awards
Website
novartis.com

† FY2026 obligations (provisional; DoD awards signed after Jul 28, 2026 are not yet public).

‡ FY2027 to date.

Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 28, 2026 are not yet public.

All federal contractors in New JerseyHow these figures are built

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI NG61ZA8TADW3. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2008. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2027: $8,397,013 (to date)
  • FY2026: $40,085,448 (provisional)
  • FY2025: $8,640,841
  • FY2023: -$18,841,773 (de-obligation)
  • FY2022: $7,393,435
  • FY2021: $1,417,721
  • FY2020: $7,788,603
  • FY2019: $919,383
Show all 19 years
  • FY2018: $893,937
  • FY2017: $23,902,810
  • FY2016: $34,647
  • FY2015: $583,502
  • FY2014: $20,188
  • FY2013: $186,010
  • FY2012: $394,685
  • FY2011: $624,579
  • FY2010: $459,348
  • FY2009: $1,135,023
  • FY2008: $1,842,889

Total across 19 fiscal years: $85,878,289

Net de-obligation in that fiscal year (obligations withdrawn).

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • 6505Drugs and biologicals$68,042,094, 79.2%
  • AN92R&d- medical: other (applied research/exploratory development)$16,334,775, 19.0%
  • 6550In vitro diagnostic substances, reagents, test kits and sets$986,369, 1.1%
  • 6530Hosp furniture,eq,utensils & sup$175,513, 0.2%
  • 6515Med & surgical instruments,eq & sup$155,315, 0.2%

Capabilities

SBA certifications

No certification in the SBA profile data.

Contracts

Latest awards and orders

  1. 36C26226N0112Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  2. 36C26127N0063Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  3. 36C26127N0055Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  4. 36C26127F0023Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  5. 36C26126F0008Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  6. 36C25027N0038BPA callunder a blanket purchase agreement (BPA)Department of Veterans AffairsLatest action
  7. 36C24827N0026Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  8. 36C24726F0260Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  9. 36C24126F0136Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action
  10. 36C26126F0168Delivery orderunder a federal supply schedule (FSS)Department of Veterans AffairsLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for Novartis Pharmaceuticals Corporation lists a physical address and a separate mailing address, along with 4 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

59 Route 10

East Hanover, NJ, 07936

USA

Mailing Address

59 ROUTE 10

EAST HANOVER, NJ, 07936

USA

Government Business Contact

Yisell Rodriguez

Associate Director, Government Contracting

ONE HEALTH PLAZA

BLDG 335

East Hanover, NJ, 07936

USA

Electronic Business Contact

Mitesh Ghia

Director, Government Reporting

ONE HEALTH PLAZA

BLDG 335

East Hanover, NJ, 07936

USA

Government Business Alternate Contact

Steven Davis

ONE HEALTH PLAZA

EAST HANOVER, NJ, 07936

USA

Electronic Business Alternate Contact

John Alexander

Manager Government Reporting

ONE HEALTH PLAZA

East Hanover, NJ, 07936

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

Novartis Pharmaceuticals Corporation has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires June 17, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Manufacturer of Goods

Registration Details

Source: SAM.gov

Initial Registration

Aug 31, 2001

Last Update

Jun 18, 2026

Registration Activation

Active — Jun 18, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

11

Other contractors in New Jersey with primary NAICS 325412